FOR IMMEDIATE RELEASE
Thursday, September 15, 2011
Contact: Leah Clark Payne, Media Communication Specialist 304-696-6397


Marshall University School of Pharmacy adds new research chair

HUNTINGTON, W.Va. – Dr. John V. Schloss, an academic and industrial researcher with more than 30 years of combined experience, has been named founding chair of pharmaceutical science and research at the Marshall University School of Pharmacy. He also will serve as a member of the Pharmacy Executive Council.

“Marshall University School of Pharmacy is starting with an impressive infrastructure for teaching and research,” Schloss said. “This will be the third time I have helped start a new pharmacy program and the Marshall program has the potential to become a leader in the area of pharmacy education and pharmaceutical research. It is an exciting time to be a part of Marshall University.”

After receiving his Ph.D. from the University of Tennessee Graduate School of Biomedical Sciences, located in the Oak Ridge National Laboratory, Schloss conducted postdoctoral work in the laboratory of Prof. W. W. Cleland at the University of Wisconsin-Madison from 1978 until 1981.

Following completion of his postdoctoral work, Schloss joined the research and development division of E.I. DuPont de Nemours & Co. in Wilmington, Del., where he held positions as a principal investigator and research supervisor. While at DuPont, Schloss published nearly three dozen papers and presented at more than 60 international and national conferences.

Beginning in 1991, Schloss served as professor and chair of the department of medicinal chemistry in the University of Kansas College of Pharmacy. He maintained his affiliation with the pharmacy program in Kansas until 2005. During this time he helped develop a new pharmacy program as part of the Kuwait Health Sciences Center, while maintaining his research programs at the University of Kansas.    

In 2002, Schloss co-founded ThioPharma Inc., a biotech startup company focused on discovery-stage pharmaceuticals. While managing ThioPharma from 2002 to 2008, he served as director of chemistry at NeuroSystec, another biotech startup focused on site specific drug delivery to the inner ear, and was principal investigator on two grants funded by the National Institutes of Health. One of the grants was from the National Institute on Alcohol Abuse and Alcoholism and the other was from the National Institute on Deafness and Other Communication Disorders. 

Schloss’ expertise in developing a school of pharmacy was tapped again in 2008, when he joined the University of New England. As a founding faculty member and chair of the department of pharmaceutical sciences, Schloss continued his research activities while developing curriculum, recruiting faculty and teaching.

“Dr. Schloss has an extensive background in both the scholarship and discovery in pharmaceutical sciences and will provide excellent leadership for the department’s development,” Dr. Kevin Yingling, dean of the school of pharmacy, said. “He is a fantastic addition to our team and we are happy to welcome him.”

Schloss has received many honors, as well as several notable research awards and grants, including a DuPont Agricultural Products Department, Research and Development Division Accomplishment Award, a Gustavus and Louise Pfeiffer Research Foundation grant, National Institutes of Health grants, Office of Naval Research grants, US-Israel Binational Research Foundation grants and Maine Technology Institute grants. He also has provided substantial service to his profession through organizational leadership.

For more information, contact Schloss at 304-696-3094.



For further information, contact:  Office of University Communications
Marshall University | 213 Old Main | Huntington, WV 25755-1090
Fax: (304) 696-3197